Clinical Trials Directory

Trials / Completed

CompletedNCT04547634

Telerehabilitation in Oncology Patients

Effect of a Telerehabilitation-exercise Intervention in Oncology Patients in the Covid-19 Pandemic

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Malaga · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The aim is to analyze the feasibility and effect of an online Therapeutic Exercise and Education programme (TEEP) in cancer patient and survivors

Detailed description

Current literature shows that Therapeutic Exercise has multiple benefits in oncology patients, such as improvements in function and quality of life, and ameliorates symptoms such as cancer-related fatigue. Furthermore, given the risk of obesity, both exercise and diet play a key role in recovery from cancer. In fact, current guidelines support the use of exercise with therapeutic purposes as a complement to cancer treatment. As a consequence of the COVID-19 pandemic, oncology patients present more difficulties to attend programs, as the vast majority are immunosuppressed, and they are considered risk population. Therefore, new online (TEEP) must be developed to facilitate the benefits of these programs in the post-COVID Era. This study analyses the feasibility (in terms of suitability and verification of exercise prescription, absence and attendance type, and total days of attendance) and the effect (in weight, physical function, and symptoms) in cancer patients and survivors.

Conditions

Interventions

TypeNameDescription
OTHERTherapeutic Exercise and EducationThe intervention will consist of 30 minutes of strength exercises followed by 20 minutes of endurance with aerobic training, individualized based on the evaluations of muscular strength and endurance. Sessions lasted 1 hour, carried out twice a week, for 12 weeks. This intervention will be complemented by nutritional education.

Timeline

Start date
2023-10-01
Primary completion
2024-11-01
Completion
2024-12-01
First posted
2020-09-14
Last updated
2026-04-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04547634. Inclusion in this directory is not an endorsement.